JP2016535781A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016535781A5 JP2016535781A5 JP2016552446A JP2016552446A JP2016535781A5 JP 2016535781 A5 JP2016535781 A5 JP 2016535781A5 JP 2016552446 A JP2016552446 A JP 2016552446A JP 2016552446 A JP2016552446 A JP 2016552446A JP 2016535781 A5 JP2016535781 A5 JP 2016535781A5
- Authority
- JP
- Japan
- Prior art keywords
- component
- composition
- composition according
- ionic liquid
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 claims description 47
- 239000002608 ionic liquid Substances 0.000 claims description 21
- 150000001768 cations Chemical class 0.000 claims description 11
- 125000000129 anionic group Chemical group 0.000 claims description 10
- 125000002091 cationic group Chemical group 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 9
- 150000003839 salts Chemical group 0.000 claims description 9
- 208000017520 skin disease Diseases 0.000 claims description 8
- 201000010099 disease Diseases 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- -1 fatty acid salt Chemical class 0.000 claims description 5
- ZHYZQXUYZJNEHD-VQHVLOKHSA-N geranic acid Chemical compound CC(C)=CCC\C(C)=C\C(O)=O ZHYZQXUYZJNEHD-VQHVLOKHSA-N 0.000 claims description 5
- 229930008392 geranic acid Natural products 0.000 claims description 5
- 230000000813 microbial effect Effects 0.000 claims description 5
- ZHYZQXUYZJNEHD-UHFFFAOYSA-N trans-geranic acid Natural products CC(C)=CCCC(C)=CC(O)=O ZHYZQXUYZJNEHD-UHFFFAOYSA-N 0.000 claims description 5
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 4
- 229960001231 choline Drugs 0.000 claims description 4
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 231100000344 non-irritating Toxicity 0.000 claims description 3
- UDWXLZLRRVQONG-UHFFFAOYSA-M sodium hexanoate Chemical compound [Na+].CCCCCC([O-])=O UDWXLZLRRVQONG-UHFFFAOYSA-M 0.000 claims description 3
- AHXNYDBSLAVPLY-UHFFFAOYSA-M 1,1,1-trifluoro-N-(trifluoromethylsulfonyl)methanesulfonimidate Chemical compound [O-]S(=O)(=NS(=O)(=O)C(F)(F)F)C(F)(F)F AHXNYDBSLAVPLY-UHFFFAOYSA-M 0.000 claims description 2
- GNPSDJOWGWWXSS-UHFFFAOYSA-M 1-benzylpyridin-1-ium;chloride Chemical compound [Cl-].C=1C=CC=C[N+]=1CC1=CC=CC=C1 GNPSDJOWGWWXSS-UHFFFAOYSA-M 0.000 claims description 2
- LZZAIUPBRFPFDS-UHFFFAOYSA-N 3-(dimethylazaniumyl)pentadecane-3-sulfonate Chemical compound CCCCCCCCCCCCC(CC)(N(C)C)S(O)(=O)=O LZZAIUPBRFPFDS-UHFFFAOYSA-N 0.000 claims description 2
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims description 2
- 208000010201 Exanthema Diseases 0.000 claims description 2
- 206010016936 Folliculitis Diseases 0.000 claims description 2
- 206010017533 Fungal infection Diseases 0.000 claims description 2
- 239000005792 Geraniol Substances 0.000 claims description 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims description 2
- 208000031888 Mycoses Diseases 0.000 claims description 2
- 206010052428 Wound Diseases 0.000 claims description 2
- 208000027418 Wounds and injury Diseases 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 206010000496 acne Diseases 0.000 claims description 2
- 201000008937 atopic dermatitis Diseases 0.000 claims description 2
- 229960003872 benzethonium Drugs 0.000 claims description 2
- SIYLLGKDQZGJHK-UHFFFAOYSA-N dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium Chemical compound C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 SIYLLGKDQZGJHK-UHFFFAOYSA-N 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 201000005884 exanthem Diseases 0.000 claims description 2
- 229940113087 geraniol Drugs 0.000 claims description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical class CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 229940071204 lauryl sarcosinate Drugs 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000004530 micro-emulsion Substances 0.000 claims description 2
- 150000002888 oleic acid derivatives Chemical class 0.000 claims description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 claims description 2
- 206010037844 rash Diseases 0.000 claims description 2
- 206010040872 skin infection Diseases 0.000 claims description 2
- 125000005497 tetraalkylphosphonium group Chemical group 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 150000001450 anions Chemical class 0.000 claims 9
- 239000003242 anti bacterial agent Substances 0.000 claims 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 229960005475 antiinfective agent Drugs 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 239000007844 bleaching agent Substances 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 description 11
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000013271 transdermal drug delivery Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361899294P | 2013-11-03 | 2013-11-03 | |
| US61/899,294 | 2013-11-03 | ||
| PCT/US2014/063745 WO2015066647A2 (en) | 2013-11-03 | 2014-11-03 | Ionic liquids for transdermal drug delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019030302A Division JP6674058B2 (ja) | 2013-11-03 | 2019-02-22 | 経皮薬物送達のためのイオン性液体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016535781A JP2016535781A (ja) | 2016-11-17 |
| JP2016535781A5 true JP2016535781A5 (https=) | 2017-12-07 |
Family
ID=53005413
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016552446A Withdrawn JP2016535781A (ja) | 2013-11-03 | 2014-11-03 | 経皮薬物送達のためのイオン性液体 |
| JP2019030302A Active JP6674058B2 (ja) | 2013-11-03 | 2019-02-22 | 経皮薬物送達のためのイオン性液体 |
| JP2020037741A Withdrawn JP2020097633A (ja) | 2013-11-03 | 2020-03-05 | 経皮薬物送達のためのイオン性液体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019030302A Active JP6674058B2 (ja) | 2013-11-03 | 2019-02-22 | 経皮薬物送達のためのイオン性液体 |
| JP2020037741A Withdrawn JP2020097633A (ja) | 2013-11-03 | 2020-03-05 | 経皮薬物送達のためのイオン性液体 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10449254B2 (https=) |
| EP (1) | EP3062819B1 (https=) |
| JP (3) | JP2016535781A (https=) |
| KR (1) | KR102286115B1 (https=) |
| CA (2) | CA2929630C (https=) |
| ES (1) | ES2908345T3 (https=) |
| WO (1) | WO2015066647A2 (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101801521B (zh) | 2007-05-14 | 2015-06-17 | 纽约州立大学研究基金会 | 生物膜中细菌细胞内的生理学分散响应诱导 |
| EP3395368A1 (en) * | 2014-10-30 | 2018-10-31 | Asahi Kasei Kabushiki Kaisha | Transdermal absorption enhancer and transdermal absorption enhancement aid |
| CA2931913C (en) | 2015-06-12 | 2024-03-19 | Kemira Oyj | Bitumen separation using ionic liquids comprising unsubstituted or substituted primary, secondary or tertiary amines, pyridines, amidines, guanidines and fatty acids and/or resin acids |
| JP7179354B2 (ja) * | 2016-08-29 | 2022-11-29 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 皮膚処置のためのイオン種に基づく局所処方物 |
| US11274137B1 (en) * | 2016-10-04 | 2022-03-15 | United States Of America As Represented By The Secretary Of The Air Force | Ultra-stable protein ionic liquids |
| US10828265B2 (en) | 2016-12-09 | 2020-11-10 | The Regents Of The University Of California | Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery |
| US11213497B2 (en) | 2017-06-01 | 2022-01-04 | Arizona Board Of Regents On Behalf Of Northern Arizona University | Antibiofilm formulations |
| CN111918644A (zh) * | 2017-11-17 | 2020-11-10 | 哈佛大学校长及研究员协会 | 用于内部递送的离子液体 |
| JP2019131480A (ja) * | 2018-01-29 | 2019-08-08 | 旭化成株式会社 | 経皮吸収促進剤及び経皮製剤 |
| EP3768240A4 (en) * | 2018-03-19 | 2021-12-22 | Cage Bio Inc. | COMPOSITIONS OF IONIC LIQUID FOR THE TREATMENT OF ROSACEA |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| KR101959524B1 (ko) * | 2018-09-19 | 2019-03-18 | 주식회사 우신라보타치 | 리도카인을 포함한 이온토포레시스용 점착성 카타플라스마 시스템 |
| EP3930757A1 (en) | 2019-03-01 | 2022-01-05 | President And Fellows Of Harvard College | Methods and compositions for protein delivery |
| US20220257767A1 (en) | 2019-04-03 | 2022-08-18 | President And Fellows Of Harvard College | Ionic liquids for drug delivery |
| EP3744312B1 (en) * | 2019-05-29 | 2022-03-23 | Assistance Publique, Hopitaux De Paris | Green tea catechins eutectic system |
| CN115348858A (zh) * | 2019-11-08 | 2022-11-15 | 凯奇生物公司 | 使用离子液体的托法替尼表面递送 |
| WO2021102084A1 (en) | 2019-11-22 | 2021-05-27 | President And Fellows Of Harvard College | Ionic liquids for drug delivery |
| WO2021119198A1 (en) * | 2019-12-09 | 2021-06-17 | Cage Bio, Inc. | Topical delivery of rna interference agents using ionic liquid |
| US11684594B2 (en) | 2020-05-12 | 2023-06-27 | President And Fellows Of Harvard College | Antifungal prophylaxis for cornea |
| WO2021263201A1 (en) * | 2020-06-26 | 2021-12-30 | Cage Bio Inc. | Sanitizing compositions containing ionic liquid |
| US20230372273A1 (en) * | 2020-10-05 | 2023-11-23 | Cage Bio, Inc. | Ionic liquid compositions for skin diseases and conditions |
| JP7284877B2 (ja) * | 2020-10-29 | 2023-05-31 | 久光製薬株式会社 | ロピニロール含有貼付剤及びロピニロールの皮膚透過性向上方法 |
| WO2022101490A1 (en) * | 2020-11-13 | 2022-05-19 | Universidade Do Minho | Eutectic compositions, methods and uses thereof |
| WO2022256291A1 (en) | 2021-06-01 | 2022-12-08 | President And Fellows Of Harvard College | Hydrogel devices for drug delivery to the ear |
| WO2022271537A1 (en) | 2021-06-25 | 2022-12-29 | President And Fellows Of Harvard College | Compositions and methods relating to injectable microemulsions |
| US12005134B2 (en) | 2021-06-30 | 2024-06-11 | Abe Pharmaceutical | Composition for stimulating facial hair growth and methods of manufacturing a composition for stimulating facial hair growth |
| CN118382429A (zh) | 2021-10-08 | 2024-07-23 | 哈佛大学校长及研究员协会 | 用于药物递送的离子液体 |
| EP4429704A4 (en) | 2021-11-10 | 2025-11-05 | I2O Therapeutics Inc | IONIC LIQUID COMPOSITIONS |
| CN116474153B (zh) * | 2022-01-17 | 2024-09-27 | 四川大学 | 一种基于竹纤维-低共熔溶剂-明胶的皮肤溃疡护理贴膜 |
| US12109303B2 (en) | 2022-04-18 | 2024-10-08 | ISHA Therapeutics LLC | Orally dissolving antimicrobial film compositions and methods of their use |
| CN115671285B (zh) * | 2022-08-24 | 2024-01-05 | 上海市皮肤病医院 | 一种抗真菌溶液及其制备方法和应用 |
| WO2025147130A1 (ko) * | 2024-01-03 | 2025-07-10 | 주식회사 바이온리퀴드 | 이온성 액체 또는 공융 용매를 이용한 신규 약물제형 |
| WO2026041873A1 (en) * | 2024-08-21 | 2026-02-26 | The University Of Reading | Compositions for systemic administration |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3342840A (en) * | 1964-03-23 | 1967-09-19 | Shell Oil Co | Cationic ester production |
| US4042327A (en) | 1976-01-15 | 1977-08-16 | Waters Associates, Inc. | Ion-pairing chromatography |
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| JPS62209523A (ja) | 1986-03-11 | 1987-09-14 | Fuji Photo Film Co Ltd | 感光材料 |
| US4892737A (en) * | 1988-09-22 | 1990-01-09 | University Of Florida | Composition and method for enhancing permeability of topical drugs |
| HU203372B (en) | 1989-02-24 | 1991-07-29 | Richter Gedeon Vegyeszet | Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient |
| US5714331A (en) | 1991-05-24 | 1998-02-03 | Buchardt, Deceased; Ole | Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
| US5487994A (en) | 1992-04-03 | 1996-01-30 | The Johns Hopkins University | Insertion and deletion mutants of FokI restriction endonuclease |
| US5356802A (en) | 1992-04-03 | 1994-10-18 | The Johns Hopkins University | Functional domains in flavobacterium okeanokoites (FokI) restriction endonuclease |
| US5527675A (en) | 1993-08-20 | 1996-06-18 | Millipore Corporation | Method for degradation and sequencing of polymers which sequentially eliminate terminal residues |
| DE4331012A1 (de) | 1993-09-13 | 1995-03-16 | Bayer Ag | Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik |
| US5674908A (en) | 1993-12-20 | 1997-10-07 | Life Technologies, Inc. | Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
| ZA952521B (en) * | 1994-03-28 | 1996-03-15 | Univ Columbia | Composition for inactivating irritants in fluids |
| KR19990022598A (ko) | 1995-06-07 | 1999-03-25 | 다니엘 엘. 캐시앙, 헨리 엘. 노르호프 | 미셀 보호 분석법 |
| US5786571A (en) | 1997-05-09 | 1998-07-28 | Lexmark International, Inc. | Wrapped temperature sensing assembly |
| ATE384554T1 (de) * | 2001-12-21 | 2008-02-15 | Rhodia | Kombinierte stabile kationische und anionische tensidzusammensetzungen |
| US7102000B2 (en) * | 2002-03-08 | 2006-09-05 | Incyte San Diego Inc. | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
| US6858217B2 (en) * | 2002-03-22 | 2005-02-22 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Stabilization of terpenoids in cosmetic compositions |
| DE602005010812D1 (de) | 2004-11-22 | 2008-12-18 | Hisamitsu Pharmaceutical Co | Transdermales Pflaster enthaltend einen schmelzpunktsenkenden Hilfsstoff |
| US9139850B2 (en) | 2005-05-19 | 2015-09-22 | L'oreal | Vectorization of dsRNA by cationic particles and topical use |
| EP2016056A4 (en) | 2006-04-21 | 2010-11-10 | Univ Boston | IONIC VISCOELASTIC AND VISCOELASTIC SALTS |
| WO2008031105A1 (en) * | 2006-09-08 | 2008-03-13 | Delaval Holdings Ab | Polymeric guanidine salt-based germicides |
| JP5117732B2 (ja) * | 2007-01-29 | 2013-01-16 | 株式会社 メドレックス | 外用剤用の低刺激性溶解助剤 |
| JP4952272B2 (ja) | 2007-01-29 | 2012-06-13 | 株式会社ツムラ | （ｚ）−リグスチリドの製造方法 |
| US8247198B2 (en) | 2007-09-21 | 2012-08-21 | Friedrich Srienc | Enzymatic processing in deep eutectic solvents |
| AU2008327436B2 (en) | 2007-11-22 | 2013-09-05 | Medrx Co., Ltd. | External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
| US8022014B2 (en) | 2008-03-26 | 2011-09-20 | Shrieve Chemical Products, Inc. | Deep eutectic solvents and applications |
| WO2010109544A1 (ja) | 2009-03-27 | 2010-09-30 | 株式会社メドレックス | 核酸を有効成分とする外用剤組成物 |
| WO2011056545A2 (en) * | 2009-10-26 | 2011-05-12 | Trustees Of Boston University | Antimicrobial ionic liquids |
| WO2011057209A1 (en) | 2009-11-06 | 2011-05-12 | Qlt, Inc. | Acidic ophthalmic formulations |
| HUE041436T2 (hu) | 2009-12-10 | 2019-05-28 | Univ Minnesota | Tal-effektor-közvetített DNS-módosítás |
| EP2773366B1 (en) | 2011-11-04 | 2017-03-01 | Lipotec, S.A. | Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions |
| EP2597099B1 (en) | 2011-11-23 | 2018-08-15 | King Saud University | Deep eutectic solvent and method for its preparation |
| EP2740484A1 (en) | 2012-12-05 | 2014-06-11 | Lipotec, S.A. | Compounds useful in the treatment and/or care of the skin, hair and/or muccous membranes and their cosmetic or pharmaceutical compositions |
| FR3002452B1 (fr) | 2013-02-28 | 2016-02-12 | Dermaconcept Jmc | Composition dermatologique antimicrobienne topique |
| CN105434337B (zh) | 2015-04-03 | 2019-08-16 | 武汉科福新药有限责任公司 | 盐酸普萘洛尔亚微乳凝胶及其制备方法和用途 |
-
2014
- 2014-11-03 US US15/034,138 patent/US10449254B2/en active Active
- 2014-11-03 KR KR1020167014980A patent/KR102286115B1/ko active Active
- 2014-11-03 CA CA2929630A patent/CA2929630C/en active Active
- 2014-11-03 JP JP2016552446A patent/JP2016535781A/ja not_active Withdrawn
- 2014-11-03 WO PCT/US2014/063745 patent/WO2015066647A2/en not_active Ceased
- 2014-11-03 EP EP14859243.9A patent/EP3062819B1/en active Active
- 2014-11-03 ES ES14859243T patent/ES2908345T3/es active Active
- 2014-11-03 CA CA3100536A patent/CA3100536A1/en not_active Abandoned
-
2019
- 2019-02-22 JP JP2019030302A patent/JP6674058B2/ja active Active
- 2019-06-21 US US16/448,335 patent/US11786597B2/en active Active
-
2020
- 2020-03-05 JP JP2020037741A patent/JP2020097633A/ja not_active Withdrawn
-
2023
- 2023-09-22 US US18/472,966 patent/US20240156964A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016535781A5 (https=) | ||
| JP2019073561A5 (https=) | ||
| US12134628B2 (en) | Antimicrobial organosilanes | |
| JP6267218B2 (ja) | 揮発性、疎水性溶媒を用いた生物学的に活性な薬剤の送達 | |
| PH12017502092A1 (en) | Topical pharmaceutical compositions | |
| NZ711225A (en) | A pharmaceutical formulation comprising omecamtiv mecarbil, processess and uses | |
| AU2019219767A1 (en) | Treatments for resistant acne | |
| JP2015500794A5 (https=) | ||
| WO2018191450A3 (en) | GENE THERAPY FOR A DEFICIENCY IN AADC | |
| MX2018004376A (es) | Formulaciones inyectables de neuroesteroides que contienen nanoparticulas. | |
| WO2015066647A3 (en) | Ionic liquids for transdermal drug delivery | |
| MX2019013701A (es) | Metodos para mejorar suministro de farmacos y efectividad de agentes terapeuticos. | |
| MY199903A (en) | Combination therapy with controlled-release cnp agonists | |
| CN105848640A (zh) | 包含聚己内酯聚合物的局部用凝胶组合物以及用于增强有益剂的局部施用的方法 | |
| JP2018512454A5 (https=) | ||
| KR20120022930A (ko) | 은 설파디아진 및 키토산을 사용하여 제조한 약용 크림 및 이의 제조 방법 | |
| EP4552650A3 (en) | Methods and compositions for treatment of skin | |
| MX2016009063A (es) | Preparacion farmaceutica que contiene compuesto de acido piridilaminoacetico. | |
| JP2018509388A5 (https=) | ||
| RU2014150505A (ru) | Способ идентификации лигандов рецептора ahr, которые обладают терапевтической себосупрессивной активностью, и указанные лиганды | |
| EP4659740A3 (en) | Kx2-391/kx-01 for use in the treatment of actinic keratosis | |
| MX395613B (es) | COMPOSICIONES DE ZINC-y-PGA Y MÉTODOS PARA TRATAR EL CANCER. | |
| SG11201908234WA (en) | Pharmaceutical composition comprising compound capable of penetrating blood-brain barrier as effective ingredient for preventing or treating brain cancer | |
| MX2023009600A (es) | Análogos de la oxa-ibogaína para el tratamiento de trastornos por consumo de sustancias. | |
| AR109012A1 (es) | Sistema de administración transdérmica que contiene galantamina o sales de esta |